ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,434,725 | +7.9% | 145,276 | 0.0% | 0.51% | +20.0% |
| Q2 2023 | $7,820,207 | -35.7% | 145,276 | -52.6% | 0.42% | -41.0% |
| Q1 2023 | $12,165,322 | -8.8% | 306,277 | -7.7% | 0.72% | -13.0% |
| Q4 2022 | $13,343,929 | +22.7% | 331,691 | -2.0% | 0.83% | +20.2% |
| Q3 2022 | $10,876,000 | +2.7% | 338,398 | -5.2% | 0.69% | +11.9% |
| Q2 2022 | $10,588,000 | +25.8% | 356,865 | +19.2% | 0.61% | +65.1% |
| Q1 2022 | $8,419,000 | +104.1% | 299,493 | +234.7% | 0.37% | +156.6% |
| Q4 2021 | $4,124,000 | +40.0% | 89,491 | -14.1% | 0.14% | -48.6% |
| Q3 2014 | $2,945,000 | -17.9% | 104,134 | 0.0% | 0.28% | -14.5% |
| Q2 2014 | $3,586,000 | +83.7% | 104,134 | +67.2% | 0.33% | +76.5% |
| Q1 2014 | $1,952,000 | – | 62,277 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |